RE:Little Unexpected But I’ll take itReading the release and TSX.com/Venture50. this was for the period of Jan 1, 2021-December 31, 2021...odd its 2022 Venture 50...should really be 2021 Venture 50, but alas it was recognized at the end of February 2022.
All in all, this and the US Patent release from yesterday on 2 of THRM products (Therozap and Intercept) should demonstrate to shareholders this is a legitimate public firm. And even though these are not the press releases we all want to read at this moment (FDA EUA submission, FDA EUA approval and AcuVid sales) its what the Company has to share to hopefully instill confidence..
We're on Company Time, Company is not on our time. Company is only on Market time. Shareholders can send a message (ie. their vote of confidence) of the Company thru the Market, which they have. The Market will communicate this message (ie vote of confidence) to the Company. And the Company will need to respond to its shareholders and customers, and rebuild that confidence.
Its a nice circle. Shareholders tell the Market what they think, Market tells the Company where its at on valuation, Company shares its news with shareholders to inspire trust and investment. A never ending circle of discussions and information sharing.